These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 7531000

  • 1. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C.
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [Abstract] [Full Text] [Related]

  • 2. In vitro simulation of thrombolysis inhibition.
    Stief TW.
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):234-7. PubMed ID: 18160584
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin.
    Iwamoto M.
    Thromb Diath Haemorrh; 1975 Jun 30; 33(3):573-85. PubMed ID: 125463
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Discreplasminin, a plasmin inhibitor isolated from Tityus discrepans scorpion venom.
    Brazón J, D'Suze G, D'Errico ML, Arocha-Piñango CL, Guerrero B.
    Arch Toxicol; 2009 Jul 30; 83(7):669-78. PubMed ID: 19015833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM, Kalnoski MH, Frederick M, Chandler WL.
    Thromb Res; 2005 Jul 30; 115(4):327-40. PubMed ID: 15668193
    [Abstract] [Full Text] [Related]

  • 11. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B, Rojas G, Vranckx R, Lijnen HR, Anglés-Cano E.
    FEBS J; 2005 Jul 30; 272(13):3387-400. PubMed ID: 15978044
    [Abstract] [Full Text] [Related]

  • 12. CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties.
    Dietrich W, Nicklisch S, Koster A, Spannagl M, Giersiefen H, van de Locht A.
    Anesthesiology; 2009 Jan 30; 110(1):123-30. PubMed ID: 19104179
    [Abstract] [Full Text] [Related]

  • 13. Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay.
    Longstaff C, Locke M.
    J Thromb Haemost; 2019 Jan 30; 17(1):195-205. PubMed ID: 30451372
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD, Moore HB, Kong YW, Chapman MP, Sriram G, Lim D, Moore EE, Yaffe MB.
    J Trauma Acute Care Surg; 2019 Jan 30; 86(1):101-107. PubMed ID: 30575685
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
    Renckens R, Weijer S, de Vos AF, Pater JM, Meijers JC, Hack CE, Levi M, van der Poll T.
    Arterioscler Thromb Vasc Biol; 2004 Mar 30; 24(3):483-8. PubMed ID: 14739127
    [Abstract] [Full Text] [Related]

  • 18. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
    Cheng AC, Tsai IH.
    Biochim Biophys Acta; 2014 Jan 30; 1840(1):153-9. PubMed ID: 23999090
    [Abstract] [Full Text] [Related]

  • 19. Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot.
    Takada A, Ito T, Takada Y.
    Thromb Haemost; 1980 Feb 29; 43(1):20-3. PubMed ID: 6447383
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.